Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.30 (
PARP
)
13,611
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The neurite outgrowth inhibitor protein Nogo-A has been identified as an inhibitor of axonal regeneration, and Nogo-B as a regulator of vasculature remodeling, but the additional roles of Nogo isoforms, especially
Nogo-C
, have obtained little attention.
Nogo-C
is weakly expressed in liver and kidney compared to the high expression in skeletal muscle. Here we detected the weak expression of
Nogo-C
in human embryonic kidney cell line HEK293, and found that
Nogo-C
expressed in HEK293 could induce cell apoptosis. Further experiments demonstrated the activation of JNK/SAPK and c-Jun, but not p38 in
Nogo-C
expressed cells. And JNK-specific inhibitor SP600125 could reduce cell apoptosis induced by
Nogo-C
. Furthermore, the activation of caspase-3 and
PARP
, the expression and phosphorylation of p53 were also detected. The data first revealed
Nogo-C
expressed in HEK293 confers apoptosis by inducing caspase-3 and p53 activation through the JNK-c-Jun-dependent pathway.
...
PMID:Human Nogo-C overexpression induces HEK293 cell apoptosis via a mechanism that involves JNK-c-Jun pathway. 1690 19